A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

May 31, 2026

Conditions
Ulcerative Colitis
Interventions
DRUG

Rosnilimab

PD-1 agonist antibody

DRUG

Placebo

Administered via SC

Trial Locations (100)

13501

AnaptysBio Investigational Site 10-133, Utica

30328

AnaptysBio Investigational Site 10-122, Atlanta

32789

AnaptysBio Investigational Site 10-131, Orlando

32822

AnaptysBio Investigational Site 10-123, Orlando

33014

AnaptysBio Investigational Site 10-109, Miami Gardens

33165

AnaptysBio Investigational Site 10-106, Miami

33607

AnaptysBio Investigational Site 10-125, Tampa

34601

AnaptysBio Investigational Site 10-127, Brooksville

37663

AnaptysBio Investigational Site 10-103, Kingsport

45201

AnaptysBio Investigational Site 10-136, Cincinnati

60453

AnaptysBio Investigational Site 10-124, Oak Lawn

73017

AnaptysBio Investigational Site 10-120, Norman

75044

AnaptysBio Investigational Site 10-113, Garland

75246

AnaptysBio Investigational Site 10-104, Dallas

75701

AnaptysBio Investigational Site 10-132, Tyler

76092

AnaptysBio Investigational Site 10-130, Southlake

78626

AnaptysBio Investigational Site 10-135, Georgetown

79382

AnaptysBio Investigational Site 10-134, Lubbock

85018

AnaptysBio Investigational Site 10-115, Phoenix

89128

AnaptysBio Investigational Site 10-118, Las Vegas

92845

AnaptysBio Investigational Site 10-117, Garden Grove

93534

AnaptysBio Investigational Site 10-112, Lancaster

AnaptysBio Investigational Site 10-129, Lancaster

95124

AnaptysBio Investigational Site 10-108, San Jose

98195

AnaptysBio Investigational Site 10-107, Seattle

Unknown

AnaptysBio Investigational Site 12-101, Innsbruck

AnaptysBio Investigational Site 12-104, Salzburg

AnaptysBio Investigational Site 12-103, Sankt Pölten

AnaptysBio Investigational Site 12-102, Vienna

AnaptysBio Investigational Site 61-102, Sofia

AnaptysBio Investigational Site 11-102, London

AnaptysBio Investigational Site 11-103, Montreal

AnaptysBio Investigational Site 11-105, Calgary

AnaptysBio Investigational Site 74-104, Rijeka

AnaptysBio Investigational Site 74-101, Zagreb

AnaptysBio Investigational Site 16-102, Nantes

AnaptysBio Investigational Site 16-103, Nantes

AnaptysBio Investigational Site 16-101, Tours

AnaptysBio Investigational Site 17-107, Berlin

AnaptysBio Investigational Site 17-106, Brandenburg

AnaptysBio Investigational Site 17-105, Dachau

AnaptysBio Investigational Site 17-101, Duisburg

AnaptysBio Investigational Site 17-110, Erlangen

AnaptysBio Investigational Site 17-108, Hamburg

AnaptysBio Investigational Site 17-103, Kiel

AnaptysBio Investigational Site 17-109, Ulm

AnaptysBio Investigational Site 20-112, Bologna

AnaptysBio Investigational Site 20-111, Cagliari

AnaptysBio Investigational Site 20-110, Catania

AnaptysBio Investigational Site 20-108, Legnano

AnaptysBio Investigational Site 20-105, Milan

AnaptysBio Investigational Site 20-107, Pavia

AnaptysBio Investigational Site 20-102, Rozzano

AnaptysBio Investigational Site 20-109, San Donato

AnaptysBio Investigational Site 20-104, San Giovanni

AnaptysBio Investigational Site 20-113, Turin

AnaptysBio Investigational Site 20-106, Udine

AnaptysBio Investigational Site 21-101, Amsterdam

AnaptysBio Investigational Site 30-108, Bydgoszcz

AnaptysBio Investigational Site 30-106, Częstochowa

AnaptysBio Investigational Site 30-112, Elblag

AnaptysBio Investigational Site 30-102, Katowice

AnaptysBio Investigational Site 30-115, Katowice

AnaptysBio Investigational Site 30-111, Krakow

AnaptysBio Investigational Site 30-123, Krakow

AnaptysBio Investigational Site 30-103, Lodz

AnaptysBio Investigational Site 30-119, Lodz

AnaptysBio Investigational Site 30-114, Lublin

AnaptysBio Investigational Site 30-104, Poznan

AnaptysBio Investigational Site 30-117, Poznan

AnaptysBio Investigational Site 30-120, Poznan

AnaptysBio Investigational Site 30-116, Rzeszów

AnaptysBio Investigational Site 30-113, Sopot

AnaptysBio Investigational Site 30-110, Torun

AnaptysBio Investigational Site 30-101, Warsaw

AnaptysBio Investigational Site 30-107, Warsaw

AnaptysBio Investigational Site 30-109, Warsaw

AnaptysBio Investigational Site 30-101, Bucharest

AnaptysBio Investigational Site 31-103, Cluj-Napoca

AnaptysBio Investigational Site 31-102, Timișoara

AnaptysBio Investigational Site 58-101, Belgrade

AnaptysBio Investigational Site 58-103, Belgrade

AnaptysBio Investigational Site 58-104, Belgrade

AnaptysBio Investigational Site 58-105, Belgrade

AnaptysBio Investigational Site 58-102, Zrenjanin

AnaptysBio Investigational Site 24-102, Alicante

AnaptysBio Investigational Site 24-103, Lleida

AnaptysBio Investigational Site 27-103, Belfast

AnaptysBio Investigational Site 27-102, Cambridge

AnaptysBio Investigational Site 27-106, Liverpool

AnaptysBio Investigational Site 27-101, London

AnaptysBio Investigational Site 27-105, Runcorn

AnaptysBio Investigational Site 27-107, Shrewsbury

AnaptysBio Investigational Site 27-104, York

0160

AnaptysBio Investigational Site 59-101, Tbilisi

AnaptysBio Investigational Site 59-104, Tbilisi

0101

AnaptysBio Investigational Site 59-106, Tbilisi

0102

AnaptysBio Investigational Site 59-103, Tbilisi

0141

AnaptysBio Investigational Site 59-102, Tbilisi

0180

AnaptysBio Investigational Site 59-105, Tbilisi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AnaptysBio, Inc.

INDUSTRY